Cargando…

Validation of the GenesWell BCT Score in Young Asian Women With HR+/HER2− Early Breast Cancer

BACKGROUND: The prognostic or predictive value of commonly used multigene assays in young patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2−) early breast cancer is unclear. In this study, we assessed the prognostic value of the GenesWell BCT assa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kwon, Mi Jeong, Ryu, Jai Min, Cho, Soo Youn, Nam, Seok Jin, Kim, Seok Won, Lee, Jeeyeon, Lee, Soo Jung, Park, Ji-Young, Park, Ho Yong, Hong, Sungjun, Kim, Kyunga, Han, Jinil, Moon, Youngho, Shin, Young Kee, Lee, Jeong Eon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7942224/ https://www.ncbi.nlm.nih.gov/pubmed/33708625 http://dx.doi.org/10.3389/fonc.2021.588728

Ejemplares similares

Comparison of GenesWell BCT Score With Oncotype DX Recurrence Score for Risk Classification in Asian Women With Hormone Receptor-Positive, HER2-Negative Early Breast Cancer
por: Kwon, Mi Jeong, et al.
Publicado: (2019)

BCT score predicts chemotherapy benefit in Asian patients with hormone receptor-positive, HER2-negative, lymph node-negative breast cancer
por: Kwon, Mi Jeong, et al.
Publicado: (2018)

A new molecular prognostic score for predicting the risk of distant metastasis in patients with HR+/HER2− early breast cancer
por: Gong, Gyungyub, et al.
Publicado: (2017)

Lead-Free AE Sensor Based on BZT–BCT Ceramics
por: Shin, Dong-Jin, et al.
Publicado: (2021)

MMP11 and CD2 as novel prognostic factors in hormone receptor-negative, HER2-positive breast cancer
por: Han, Jinil, et al.
Publicado: (2017)

The Impact of HER2-Low Expression on Oncologic Outcomes in Hormone Receptor-Positive Breast Cancer
por: Park, Woong Ki, et al.
Publicado: (2023)

Relationship Between Breast and Axillary Pathologic Complete Response According to Clinical Nodal Stage: A Nationwide Study From Korean Breast Cancer Society
por: Ryu, Jai Min, et al.
Publicado: (2022)

Clinicopathological Features of Patients with the BRCA1 c.5339T>C (p.Leu1780Pro) Variant
por: Park, Hyung Seok, et al.
Publicado: (2020)

Clinicopathologic characteristics of HER2-positive pure mucinous carcinoma of the breast
por: Jang, Yunjeong, et al.
Publicado: (2020)

Real World Evidence of Neoadjuvant Docetaxel/Carboplatin/Trastuzumab/Pertuzumab (TCHP) in Patients with HER2-Positive Early or Locally Advanced Breast Cancer: A Single-Institutional Clinical Experience
por: Kim, Ji-Yeon, et al.
Publicado: (2022)

Predicting the Response of Neoadjuvant Chemotherapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer With Axillary Lymph Node Metastasis by Multigene Assay
por: Lee, Jun-Hee, et al.
Publicado: (2022)

Predictive biological factors for late survival in patients with HER2-positive breast cancer
por: Kang, Young-Joon, et al.
Publicado: (2023)

Utility of (18)F-FDG PET/CT for predicting pathologic complete response in hormone receptor-positive, HER2-negative breast cancer patients receiving neoadjuvant chemotherapy
por: Lee, In Hee, et al.
Publicado: (2020)

Dimerization of EGFR and HER2 induces breast cancer cell motility through STAT1-dependent ACTA2 induction
por: Jeon, Myeongjin, et al.
Publicado: (2016)

A functional comparison between the HER2(high)/HER3 and the HER2(low)/HER3 dimers on heregulin-β1-induced MMP-1 and MMP-9 expression in breast cancer cells
por: Kim, Sangmin, et al.
Publicado: (2012)

UBE2C Overexpression Aggravates Patient Outcome by Promoting Estrogen-Dependent/Independent Cell Proliferation in Early Hormone Receptor-Positive and HER2-Negative Breast Cancer
por: Kim, Yu-Jin, et al.
Publicado: (2020)

Benefit of postoperative regional nodal irradiation in patients receiving preoperative systemic therapy with docetaxel/carboplatin/trastuzumab/pertuzumab for HER2-positive breast cancer
por: Kim, Nalee, et al.
Publicado: (2023)

Suppression of Platelet-Derived Growth Factor Receptor-Alpha Overcomes Resistance to Trastuzumab through STAT3-Dependent IL-6 Reduction in HER2-Positive Breast Cancer Cells
por: Kim, Sangmin, et al.
Publicado: (2023)

Improved Prediction of Survival Outcomes Using Residual Cancer Burden in Combination With Ki-67 in Breast Cancer Patients Underwent Neoadjuvant Chemotherapy
por: Kim, Ji-Yeon, et al.
Publicado: (2022)

Progesterone Receptor Expression Level Predicts Prognosis of Estrogen Receptor-Positive/HER2-Negative Young Breast Cancer: A Single-Center Prospective Cohort Study
por: Kwak, Youngji, et al.
Publicado: (2023)

Impact of Skeletal Muscle Loss and Visceral Obesity Measured Using Serial CT on the Prognosis of Operable Breast Cancers in Asian Patients
por: Kwon, Mi-ri, et al.
Publicado: (2022)

The Early- to Mid-term Outcome of Novel Cementless Modular Femoral Stem in East Asian Patients
por: Kim, Hong Seok, et al.
Publicado: (2023)

Clinical and Radiological Changes after Microfracture of Knee Chondral Lesions in Middle-Aged Asian Patients
por: Kim, Jong-Keun, et al.
Publicado: (2019)

Clinical significance of HER2-low expression in early breast cancer: a nationwide study from the Korean Breast Cancer Society
por: Won, Hye Sung, et al.
Publicado: (2022)

YAP1 Expression in HR+HER2− Breast Cancer: 21-Gene Recurrence Score Analysis and Public Dataset Validation
por: Park, Inho, et al.
Publicado: (2023)

Enhanced Immunogenicity of Engineered HER2 Antigens Potentiates Antitumor Immune Responses
por: Jeon, Insu, et al.
Publicado: (2020)

Conditional disease-free survival among patients with breast cancer
por: Paik, Hyun-June, et al.
Publicado: (2017)

Adjuvant endocrine therapy alone in patients with node-positive, luminal A type breast cancer
por: Park, Sungmin, et al.
Publicado: (2017)

Fertility Rates in Young Korean Breast Cancer Patients Treated with Gonadotropin-Releasing Hormone and Chemotherapy
por: Kim, Isaac, et al.
Publicado: (2017)

Diagnostic Value of FDG PET/CT in Surveillance after Curative Resection of Breast Cancer
por: Lee, Hwanhee, et al.
Publicado: (2023)

Longitudinal multi-omics study of palbociclib resistance in HR-positive/HER2-negative metastatic breast cancer
por: Park, Yeon Hee, et al.
Publicado: (2023)

Tumorigenicity of EGFR- and/or HER2-Positive Breast Cancers Is Mediated by Recruitment of Tumor-Associated Macrophages
por: You, Daeun, et al.
Publicado: (2023)

Aromatase inhibitor-associated musculoskeletal symptoms: incidence and associated factors
por: Park, Jin Young, et al.
Publicado: (2013)

Mastectomy with Reconstruction Including Robotic Endoscopic Surgery (MARRES): a prospective cohort study of the Korea Robot-Endoscopy Minimal Access Breast Surgery Study Group (KoREa-BSG) and Korean Breast Cancer Study Group (KBCSG)
por: Ryu, Jai Min, et al.
Publicado: (2023)

Oncologic Outcomes after Immediate Breast Reconstruction Following Total Mastectomy in Patients with Breast Cancer: A Matched Case-Control Study
por: Ryu, Jai Min, et al.
Publicado: (2017)

Differences in clinical outcomes between HER2-negative and HER2-positive luminal B breast cancer
por: Kang, Byeongju, et al.
Publicado: (2023)

Comparison of Core Needle Biopsy and Surgical Specimens in Determining Intrinsic Biological Subtypes of Breast Cancer with Immunohistochemistry
por: You, Kiho, et al.
Publicado: (2017)

Practical approaches to automated digital image analysis of Ki-67 labeling index in 997 breast carcinomas and causes of discordance with visual assessment
por: Kwon, Ah-Young, et al.
Publicado: (2019)

A genome-wide Asian genetic map and ethnic comparison: The GENDISCAN study
por: Ju, Young Seok, et al.
Publicado: (2008)

Dual-color fluorescent nanoparticles showing perfect color-specific photoswitching for bioimaging and super-resolution microscopy
por: Kim, Dojin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ekl4o7mvai2f3h54t3h5sb45k5